UCSF Benioff Children's Hospitals
Welcome,         Profile    Billing    Logout  
 1 Trial 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Meadows, Jeffery
COMPASS, NCT05268094: Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The Trial)

Recruiting
N/A
300
Canada, US
Ductal Arterial Stent, Medtronic Resolute Onyx, Boston Scientific Promus Elite/Premier, Boston Scientific Synergy, Cordis Elunir, Abbott Xience, Systemic-to-Pulmonary Artery Shunt
HealthCore-NERI, Pediatric Heart Network
Congenital Heart Disease in Children
03/26
09/26
Razani, Nooshin
BLOOM, NCT05973123: Boldly Living outdOOrs for Mental Health

Recruiting
N/A
126
US
Group Nature Outings, Family Outings
University of California, San Francisco
Anxiety, Stress Disorder, Posttraumatic, Loneliness, Adverse Childhood Experiences
09/23
09/23
Thakar, Himal L
Northstar-3, NCT03207009 / 2016-003611-35: A Study Evaluating the Efficacy and Safety of the LentiGlobin® BB305 Drug Product in Participants With Transfusion-Dependent β-Thalassemia

Checkmark From trial for beta-thalassemia at ASH 2020
Dec 2020 - Dec 2020: From trial for beta-thalassemia at ASH 2020
Checkmark Data from HGB-212 for transfusion-dependent beta-thalassemia at EHA 2020
Jun 2020 - Jun 2020: Data from HGB-212 for transfusion-dependent beta-thalassemia at EHA 2020
Checkmark From HGB-212 study for beta thalassemia at ASH 2019
More
Completed
3
19
Europe, US
LentiGlobin BB305 Drug Product, betibeglogene autotemcel
bluebird bio
Beta-Thalassemia
11/22
11/22
NCT03852498 / 2018-001145-14: A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Completed
3
35
Europe, US
Lenti-D, elivaldogene autotemcel, eli-cel
bluebird bio
Cerebral Adrenoleukodystrophy (CALD)
07/23
07/23
NCT06271512: A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

Recruiting
N/A
150
US
No Intervention
bluebird bio, Center for International Blood and Marrow Transplant Research
Beta-Thalassemia
12/43
12/43
Stargazer, NCT06224413: A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

Recruiting
N/A
120
US
No Intervention
bluebird bio, Center for International Blood and Marrow Transplant Research
Cerebral Adrenoleukodystrophy (CALD)
12/47
12/47
LTF-303, NCT02633943 / 2013-002245-11: Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy

Calendar Mar 2031 - Mar 2031: Completion of LTF-303 study for sickle cell disease
Active, not recruiting
N/A
66
Europe, US, RoW
Safety and efficacy assessments
bluebird bio
Transfusion-dependent Beta-Thalassemia
11/35
11/35
LTF-304, NCT02698579 / 2015-002805-13: Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated With Lenti-D Drug Product

Active, not recruiting
N/A
64
Europe, US, RoW
No interventional drug product utilized in this follow-up study
bluebird bio
Cerebral Adrenoleukodystrophy (CALD), Adrenoleukodystrophy (ALD), X-Linked Adrenoleukodystrophy (X-ALD)
08/38
08/38
Goel, Disha
NCT05767385: Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Recruiting
2/3
150
US
Single Arm, Neonatal Neurobehavioral Scale
University of Utah, Primary Children's Hospital, National Heart, Lung, and Blood Institute (NHLBI)
Congenital Heart Disease in Children, Hypoxia, Neurodevelopmental Disorders, Complex Congenital Heart Disease
12/24
12/24
COMPASS, NCT05268094: Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The Trial)

Recruiting
N/A
300
Canada, US
Ductal Arterial Stent, Medtronic Resolute Onyx, Boston Scientific Promus Elite/Premier, Boston Scientific Synergy, Cordis Elunir, Abbott Xience, Systemic-to-Pulmonary Artery Shunt
HealthCore-NERI, Pediatric Heart Network
Congenital Heart Disease in Children
03/26
09/26

Download Options